University of Oxford
π¬π§United Kingdom
- Country
- π¬π§United Kingdom
- Ownership
- Private
- Established
- 1096-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ox.ac.uk
ADITEC FLU 2 STUDY: Understanding the Genetics Basis for Immune Responses to Flu Vaccines in Children and Adults
Phase 2
Completed
- Conditions
- Influenza
- Interventions
- Biological: MF59 - ATIV
- First Posted Date
- 2015-08-20
- Last Posted Date
- 2023-12-07
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 120
- Registration Number
- NCT02529904
- Locations
- π¬π§
Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Oxford, United Kingdom
Giant Cell Arteritis: Improving Use of Ultrasound Evaluation
- Conditions
- Giant Cell Arteritis
- Interventions
- Device: Ultrasound of temporal and axillary arteries
- First Posted Date
- 2015-08-14
- Last Posted Date
- 2015-08-14
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 250
- Registration Number
- NCT02523625
MEK and MET Inhibition in Colorectal Cancer
Phase 1
Completed
- Conditions
- Solid TumorColorectal Cancer
- Interventions
- First Posted Date
- 2015-07-28
- Last Posted Date
- 2021-07-13
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 82
- Registration Number
- NCT02510001
- Locations
- π¬π§
Oxford University Hospital NHS Trust, Oxford, United Kingdom
Interferon-lambda: Novel Biologics for Controlling Neutrophil-mediated Pathology in Rheumatic Diseases?
- Conditions
- VasculitisArthritis
- First Posted Date
- 2015-07-15
- Last Posted Date
- 2017-08-02
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 85
- Registration Number
- NCT02498808
- Locations
- π¬π§
Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
A Study to Assess Ebola Vaccines ChAd3-EBO-Z and Ad26.ZEBOV
Phase 1
Completed
- Conditions
- Ebola Virus Disease
- Interventions
- Biological: ChAd3-EBO-ZBiological: Ad26.ZEBOV
- First Posted Date
- 2015-07-13
- Last Posted Date
- 2018-04-11
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 32
- Registration Number
- NCT02495246
- Locations
- π¬π§
Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Oxford, Oxfordshire, United Kingdom
Bio-availability of Rectal Artesunate in Children With Severe Falciparum Malaria
Phase 2
Completed
- Conditions
- Malaria
- Interventions
- Drug: Intrarectal artesunateDrug: Intravenous artesunateDrug: Intravenous quinine
- First Posted Date
- 2015-07-08
- Last Posted Date
- 2015-12-03
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 82
- Registration Number
- NCT02492178
- Locations
- π¨π©
Kinshasa School of Public Health, Kinshasa, Congo, The Democratic Republic of the
Evaluation of a New Ebola Vaccine Using a Short-interval Prime-boost Vaccination
Phase 1
Completed
- Conditions
- Ebola Virus Disease
- Interventions
- Biological: ChAd3-EBO ZBiological: MVA-EBO Z
- First Posted Date
- 2015-06-30
- Last Posted Date
- 2019-02-06
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 40
- Registration Number
- NCT02485912
- Locations
- πΈπ³
Centre Hospitalier Universitaire le Dantec, Dakar, Senegal
A New Rehabilitation Treatment Following Stroke
Not Applicable
Completed
- Conditions
- Stroke
- Interventions
- Behavioral: A New Rehabilitation Treatment following Stroke
- First Posted Date
- 2015-06-26
- Last Posted Date
- 2017-11-17
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 17
- Registration Number
- NCT02482688
- Locations
- π¬π§
University of Oxford, Oxford, United Kingdom
Baby Vaccine Study (Sched3)
Phase 2
Completed
- Conditions
- Infectious Diseases
- Interventions
- Biological: DTaP/IPV/Hib vaccineBiological: 13 valent Pneumococcal Conjugate VaccineBiological: Rotavirus vaccineBiological: 4-component Meningococcal B vaccineBiological: Meningococcal C/Hib vaccine (MenC/Hib vaccine)Biological: Measles/Mumps/Rubella Vaccine (MMR vaccine)
- First Posted Date
- 2015-06-26
- Last Posted Date
- 2021-09-20
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 189
- Registration Number
- NCT02482636
- Locations
- π¬π§
Centre for Clinical Vaccinology and Tropical Medicine, Oxford, Oxfordshire, United Kingdom
Understanding Liver Fat Metabolism: Studies to Understand the Role of Dietary Sugars on Liver Fat Metabolism
Not Applicable
Completed
- Conditions
- Hypertriglyceridaemia
- Interventions
- Other: Sugar study
- First Posted Date
- 2015-06-23
- Last Posted Date
- 2017-01-20
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 16
- Registration Number
- NCT02478541
- Locations
- π¬π§
Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, United Kingdom
Β© Copyright 2025. All Rights Reserved by MedPath